疫苗分配順位之科學證據與倫理考量

The Scientific Evidences and Ethical Consideration for Vaccine Allocation

薛復宸(Fu-Chen Hsueh) ； 蔡甫昌(Daniel Fu-Chang Tsai)

《台灣醫學》 26卷4期 (2022/07) Pp. 455-465

https://doi.org/10.6320/FJM.202207_26(4).0010

摘要

當新冠肺炎疫情延燒而疫苗供應卻不足時，如何進行分配應根據科學證據及倫理原則。本研究回顧英美疫苗短缺階段時，其決策單位如何納入既有科學證據，作為制訂疫苗政策之考量、比較台灣與英美疫苗接種順位之差異、並探討疫苗決策過程的民眾參與，期能提供未來台灣疫苗政策之參考。

關鍵字

新冠肺炎疫苗 ； 疫苗分配 ； 民眾參與 ； 科學證據

並列摘要

When vaccine supply is insufficient in the Covid-19 pandemic, how to allocate vaccine should be based on both scientific evidence and ethical principles. This paper introduces the UK and the US experiences of how scientific evidences were implemented in the national vaccine policies, and compares these with the policies of Taiwan, and then examines the role of public participation in vaccine policies. It is hoped that such analysis will be useful for future Taiwan policy considerations.

並列關鍵字

COVID-19 vaccine ； vaccine allocation ； public participation ； scientific evidence

參考文獻

蔡甫昌、胡嘉輝、莊宇真等：傳染病大流行下的疫苗分配與倫理。台灣醫學 2021;25:1-23。 doi: 10.6320/FJM.202101_25(1).0001

Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430-6. doi: 10.1038/s41586-020-2521-4

Mutambudzi M, Niedwiedz C, Macdonald EB, et al. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med 2020;78:307-14. doi: 10.1136/oemed-2020-106731

Clift AK, Coupland CAC, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 2020;371:m3731. doi: 10.1136/bmj.m3731

Hughes MM, Groenewold MR, Lessem SE, et al. Update: Characteristics of health care personnel with COVID-19 - United States, February 12-July 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1364-8. doi: 10.15585/mmwr.mm6938a3